Mirum Pharmaceuticals (mirm 4 05/01/29)
13F holders, Q1 2025 (March 31)3holders
0new positions
0sold out
$1.62avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Mirum Pharmaceuticals (mirm 4 05/01/29) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Sei Investments Co. ($370K), Oppenheimer Asset Management Inc. ($101K) and Stephens Inc. ($32K).
- Company
- Mirum Pharmaceuticals (mirm 4 05/01/29)
- CUSIP
- 604749AB7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 1,000 shares bought, net +1,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Sei Investments Co. | 0.00% | No change | 228,000 | $370K |
| Oppenheimer Asset Management Inc. | 0.00% | No change | 62,000 | $101K |
| Stephens Inc. | 0.00% | Add +5.3% | 20,000 | $32K |
"% of holder's portfolio" is MIRUM PHARMACEUTICALS (MIRM 4 05/01/29)'s weight in each manager's 13F, not the share of Mirum Pharmaceuticals (mirm 4 05/01/29) the manager owns.